Skip to main content
. 2021 Feb 22;80(3):240–246. doi: 10.1093/jnen/nlaa160

TABLE 1.

Demographic and Neuropathological Characteristics of Cases Evaluated by Braak Stage

Braak I–II Entorhinal Braak III–IV Limbic Braak V–VI Neocortical p Value
n = 44 n = 210 n = 101
Age at death (y) 82.39 ± 5.84 89.04 ± 6.30 85.17 ± 7.50 <0.001
Sex Male/female (% male) 31/13 (70%) 92/118 (44%) 55/46 (54%) 0.003*
Education (y) 15.36 ± 2.54 14.82 ± 2.53 14.50 ± 2.67 0.16
Consensus diagnosis (CU/MCI/AD) 37/3/4 145/26/39 1/2/98 <0.001*
APOE ε4 Carrier/noncarrier (% carrier) 8/35 (19%) 41/167 (20%) 56/44 (56%) <0.001*
Postmortem interval (hours) 2.94 (2.38, 3.50) 2.91 (2.50, 3.50) 3.00 (2.50, 3.50) 0.92
Brain weight at autopsy (g) 1,236.61 ± 140.43 1,160.81 ± 108.77 1,079.40 ± 117.84 <0.001
Lewy body pathology (yes/no) 10/34 59/151 58/43 <0.001*
CERAD neuritic plaque density <0.001*
 None 21 55 2
 Sparse 8 43 1
 Moderate 8 41 3
 Frequent 7 70 95
Circles of Willis atherosclerosis 2.09 ± 1.64 1.96 ± 1.17 2.08 ± 1.15 0.56
White matter rarefaction 2.81 ± 2.80 3.66 ± 3.05 5.47 ± 3.40 <0.001
Microinfarct number 0.02 ± 0.05 0.42 ± 1.95 0.54 ± 2.40 0.03
Cerebral amyloid angiopathy 1.57 ± 2.68 2.68 ± 3.29 5.69 ± 3.84 <0.001

Mean ± SD; Median (interquartile range) for postmortem interval.

*

p value determined via Chi-square analysis. All others determined via Kruskal-Wallis analysis.